A new research perspective was published in Volume 18 of Aging-US on February 24, 2026, titled “A decline in glycolytic ATP ...
Esperion Therapeutics Inc. has described ATP citrate lyase (ACLY) inhibitors reported to be useful for the treatment of cancer, nonalcoholic or metabolic dysfunction-associated steatohepatitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results